Data / Research funding / Post-Acute Sequelae of SARS-CoV-2 infection (PASC) including Long COVID
Post-Acute Sequelae of SARS-CoV-2 infection (PASC) including Long COVID: 185 NIH awards ($1.1B) to 97 organizations
185 NIH awards ($1.1B) in the NIH spending category Post-Acute Sequelae of SARS-CoV-2 infection (PASC) including Long COVID, to 97 organizations, read 2026-11-04. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
185 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| OTA-21-015A Post-Acute Sequelae of SARS-CoV-2 Infection Initiative: NYU Langone Health Clinical Science Core, Data Resource Core, and PASC Biorepository Core | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $650,978,035 | May 24, 2021 | May 23, 2025 | KATZ, STUART D | reporter.nih.gov |
| Interactive Data Portals and Robust Analytic Tools to Wrap PASC Cohorts (iDRAW) OTA-21-015A | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $182,207,494 | June 10, 2021 | June 9, 2024 | FOULKES, ANDREA S | reporter.nih.gov |
| Louisiana Clinical and Translational Science Center | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $25,457,946 | August 15, 2012 | June 30, 2027 | KIRWAN, JOHN P. | reporter.nih.gov |
| Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations | NIH | National Institute on Aging | 2023 to 2025 | $23,106,653 | August 15, 2023 | July 31, 2028 | DE ERAUSQUIN, GABRIEL ALEJANDRO | reporter.nih.gov |
| CODA: COvid and Diabetes Assessment | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $14,508,027 | July 21, 2023 | June 30, 2028 | ROTHMAN, RUSSELL L. | reporter.nih.gov |
| REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD | NIH | National Institute on Aging | 2024 to 2025 | $11,773,020 | January 1, 2024 | December 31, 2028 | ELY, E WESLEY | reporter.nih.gov |
| Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL | NIH | National Institute on Aging | 2022 to 2025 | $6,381,039 | September 1, 2022 | May 31, 2027 | HAINES, JONATHAN L | reporter.nih.gov |
| NBER Center for Aging and Health Research | NIH | National Institute on Aging | 2021 to 2025 | $5,663,258 | August 1, 1997 | August 31, 2027 | CUTLER, DAVID M | reporter.nih.gov |
| Alzheimer’s Disease Related Biomarkers following SARS-CoV-2 Infection | NIH | National Institute on Aging | 2022 to 2025 | $5,518,240 | June 15, 2022 | March 31, 2027 | WISNIEWSKI, THOMAS M | reporter.nih.gov |
| Establishment of a Public-Private Partnership (PPP) to Support Therapy Selection and Testing within RECOVER-TLC | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $4,755,161 | September 25, 2024 | December 31, 2026 | PENNINI, MEGHAN | reporter.nih.gov |
| Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,900,756 | February 1, 2022 | January 31, 2027 | SINGH, DHIRAJ KUMAR | reporter.nih.gov |
| At the Intersection of HIV and COVID-19: Medicaid Data as a Complement to Cohort Studies | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,843,434 | June 10, 2022 | May 31, 2027 | LAU, BRYAN | reporter.nih.gov |
| Genetic Investigation of Covid 19 in Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,774,284 | August 1, 2022 | July 31, 2027 | KAHN, MARK L | reporter.nih.gov |
| Sex specific immune response to SARS-CoV-2 leads to chronic neurologic symptoms | NIH | National Institute of Mental Health | 2021 to 2025 | $3,727,455 | September 15, 2021 | July 31, 2026 | MCCULLOUGH, LOUISE D. | reporter.nih.gov |
| Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,689,933 | July 15, 2021 | June 30, 2026 | OZ, GULIN | reporter.nih.gov |
| The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,543,436 | March 1, 2022 | February 28, 2027 | TEIJARO, JOHN ROSS | reporter.nih.gov |
| Cerebrospinal fluid (CSF) and peripheral markers of the neuropsychiatric sequelae of COVID-19: The Generation C-SF pregnancy study | NIH | National Institute of Mental Health | 2022 to 2025 | $3,477,672 | April 1, 2022 | January 31, 2027 | PEREZ RODRIGUEZ, MARIA DE LAS MERCEDES | reporter.nih.gov |
| Cardiac Magnetic Resonance for Tissue Characterization Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 Survivors | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,354,566 | September 1, 2021 | July 31, 2027 | KIM, JIWON | reporter.nih.gov |
| Temporal Phenotypes and Risk Models for the Post-COVID Syndrome and its sub-types | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,271,583 | July 15, 2022 | June 30, 2027 | ESTIRI, HOSSEIN | reporter.nih.gov |
| Leveraging Longitudinal Survey and EHR data to Dissect the Impact of COVID-19 related Stressors and Infections on Child Mental Health and Suicide Risks | NIH | National Institute of Mental Health | 2023 | $3,231,590 | September 1, 2023 | August 31, 2026 | XIAO, YUNYU | reporter.nih.gov |
| Early life B cell responses and inflammation following SARS-CoV-2 infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,160,521 | September 17, 2021 | August 31, 2026 | FOUDA AMOU OU, GENEVIEVE GINY | reporter.nih.gov |
| Cardiovascular Risk, Vascular and Kidney Damage in COVID-19 Survivors | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,114,564 | January 20, 2022 | December 31, 2026 | CHIRINOS MEDINA, JULIO ALONSO | reporter.nih.gov |
| Cardiac microstructure and the immune-inflammatory response to SARS-CoV-2 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,960,871 | April 1, 2016 | February 28, 2026 | CHENG, SUSAN | reporter.nih.gov |
| Brain signature of SARS-CoV-2 Infection and its impact on long-term cognitive functioning in older adults | NIH | National Institute on Aging | 2022 to 2025 | $2,954,828 | July 1, 2022 | June 30, 2027 | SCHIFITTO, GIOVANNI | reporter.nih.gov |
| Impact of obesity on SARS-CoV-2 infection and reciprocal effects of SARS-CoV-2 on metabolic disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,942,639 | July 1, 2023 | June 30, 2027 | KIEVIT, PAUL | reporter.nih.gov |
| Innate immune responses to SARS-CoV-2 infection in the olfactory epithelium | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2025 | $2,922,855 | April 1, 2022 | March 31, 2027 | GONG, QIZHI | reporter.nih.gov |
| Blood brain barrier integrity and immune dynamics contributing to neuropsychiatric sequela in COVID long-haulers | NIH | National Institute of Mental Health | 2023 | $2,906,437 | May 1, 2023 | April 30, 2026 | RUBIN, LEAH HELANE | reporter.nih.gov |
| COVID-19 Lung Microvascular and Parenchymal Sequelae (Lung-MaPS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,791,226 | July 15, 2021 | April 30, 2026 | OELSNER, ELIZABETH | reporter.nih.gov |
| Long-Term Endothelial Effects of COVID-19 in Obesity | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,750,534 | March 15, 2022 | February 28, 2026 | HO, JENNIFER E | reporter.nih.gov |
| Immunologic basis of cardiac disease after severe COVID-19 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,713,482 | July 1, 2022 | May 31, 2027 | SHENOY, CHETAN | reporter.nih.gov |
| Characterizing Persistent Subclinical Neurobehavioral Effects of COVID-19 in a Diverse Urban Population | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,698,545 | April 1, 2022 | March 31, 2027 | DAILY, JOHANNA PATRICIA | reporter.nih.gov |
| AMPK Regulation of ACE2 in Endothelial Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,666,121 | February 15, 2022 | January 31, 2026 | SHYY, JOHN YJ | reporter.nih.gov |
| Administrative Supplement to Investigate the Effects of Long COVID on SELA study participants | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $2,657,323 | July 28, 2021 | April 30, 2026 | RAMOS, PAULA SOFIA | reporter.nih.gov |
| Long-Term Impact of the COVID-19 Pandemic on Self-Management of Chronic Conditions: The C3 Study | NIH | National Institute on Aging | 2022 to 2025 | $2,566,628 | June 1, 2022 | March 31, 2027 | WOLF, MICHAEL S | reporter.nih.gov |
| Post-Acute Sequelae of SARS-CoV-2 Infection and Subsequent Disease Progression in Individuals with AD/ADRD: Influence of the Social and Environmental Determinants of Health | NIH | National Institute on Aging | 2023 | $2,561,480 | September 1, 2023 | August 31, 2026 | HU, HUI | reporter.nih.gov |
| Characterization of Persistent COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,560,715 | August 10, 2023 | July 31, 2027 | LI, JONATHAN | reporter.nih.gov |
| Impact of SARS-CoV-2 on the cerebrovasculature as a risk factor for VCID: Role of Wnt/beta-catenin | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $2,549,080 | August 11, 2025 | July 31, 2029 | LUTZ, SARAH ELIZABETH | reporter.nih.gov |
| Long-Term Effects of COVID-19 and Health Care Delivery Changes on Populations Living with Multiple Chronic Conditions | NIH | National Institute on Aging | 2021 to 2025 | $2,529,660 | September 30, 2021 | May 31, 2026 | STANGE, KURT C | reporter.nih.gov |
| Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2 | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,526,022 | February 5, 2023 | January 31, 2028 | ABRAMSON, STEVEN B | reporter.nih.gov |
| Long term adverse health outcomes for women and children following SARS-CoV-2 infection during pregnancy | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,418,045 | July 1, 2023 | June 30, 2028 | HEDDERSON, MONIQUE MARIE | reporter.nih.gov |
| Impact of SARS-CoV-2 infection on respiratory viral immune responses in children with and without asthma | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,408,222 | July 1, 2023 | June 30, 2028 | WORGALL, STEFAN | reporter.nih.gov |
| Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing | NIH | National Institute on Aging | 2023 | $2,394,473 | May 15, 2023 | April 30, 2026 | CHENG, FEIXIONG | reporter.nih.gov |
| Blood DNA Methylation Biomarkers of Post Acute Sequelae of SARS CoV 2 Infection (PASC) | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,365,635 | July 5, 2023 | June 30, 2028 | JAITOVICH, ADOLFO ARIEL | reporter.nih.gov |
| Quantitative Detection of Coronary Microvascular Dysfunction in Long COVID Patients using a Comprehensive, Rapid, Free-Breathing Cardiovascular MRI | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,361,031 | April 15, 2023 | March 31, 2027 | KIM, DANIEL | reporter.nih.gov |
| Host cellular network governing the development of post SARS-CoV-2 tissue sequelae | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,351,771 | February 14, 2020 | May 31, 2030 | SUN, JIE | reporter.nih.gov |
| COVID-19-related blood-brain barrier and microstructural brain injury; Sex differences and synergy with Alzheimer's disease risk | NIH | National Institute on Aging | 2023 to 2025 | $2,337,162 | December 15, 2022 | November 30, 2027 | REAS, EMILIE T. | reporter.nih.gov |
| Humoral Immune Mechanisms of Acute and Chronic Neurologic Sequelae of COVID-19 | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,260,647 | February 15, 2022 | November 30, 2025 | WILSON, MICHAEL R | reporter.nih.gov |
| Whole Body Deep Tissue Characterization of the Human Virome | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $2,255,898 | September 13, 2024 | August 31, 2029 | HENRICH, TIMOTHY JENSEN | reporter.nih.gov |
| Deep Learning and Subtyping of Post-COVID-19 Lung Progression Phenotypes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,221,683 | June 1, 2023 | February 29, 2028 | LIN, CHING-LONG | reporter.nih.gov |
| Long-term Neuropsychiatric Sequelae of SARS-CoV-2 Infection in Late Life | NIH | National Institute on Aging | 2023 to 2025 | $2,220,102 | April 1, 2023 | March 31, 2029 | BYERS, AMY LYNN | reporter.nih.gov |
| Immunologic and Clinical Sequelae after COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $2,205,056 | February 1, 2023 | January 31, 2028 | SPARKS, JEFFREY ANDREW | reporter.nih.gov |
| Cognitive sequelae of cerebrovascular and gut dysfunction in post-acute COVID-19 syndrome. | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,171,443 | July 1, 2023 | May 31, 2028 | VAKHTIN, ANDREI A | reporter.nih.gov |
| Pediatric Chronic Headache and COVID-19: Use of Machine Learning and Biobehavioral Analysis to Classify Headache Mechanism and Optimize Treatment Course. | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,140,031 | August 18, 2022 | May 31, 2027 | HOLMES, SCOTT | reporter.nih.gov |
| Assessing the Impact of SARS-CoV-2 on Adipose Tissue Function and Glucose Homeostasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,139,449 | May 1, 2023 | April 30, 2028 | LO, JAMES C | reporter.nih.gov |
| Human Herpesvirus 6B in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome pathogenesis: temporal analysis of viral reactivation and immunity to elucidate cause vs effect | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,078,193 | September 9, 2022 | August 31, 2027 | CLIFF, JACKIE | reporter.nih.gov |
| Uncover mechanisms underlying the development of chronic lung sequelae post COVID-19 | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,058,585 | August 1, 2023 | July 31, 2027 | SUN, JIE | reporter.nih.gov |
| A New Small-Molecule Kinase Inhibitor for Airway Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,038,199 | August 7, 2019 | June 30, 2027 | BROSCHAT, KAY O | reporter.nih.gov |
| Determinants of Early Childhood Immune Responses | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,017,519 | September 20, 2023 | June 30, 2028 | PRAHL, MARY | reporter.nih.gov |
| NAEOTOM Alpha Photon-Counting CT Scanner | NIH | Office of the Director, National Institutes of Health | 2024 | $2,000,000 | August 15, 2024 | November 14, 2025 | HOFFMAN, ERIC ALFRED | reporter.nih.gov |
| New Technology for High-Resolution Antibody Profiling for SARS-CoV-2 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $1,957,250 | August 19, 2022 | July 31, 2025 | LIM, MARK | reporter.nih.gov |
| Determining the Incidence, Risk Factors and Biological Drivers of Irritable Bowel Syndrome (IBS) as Part of the Constellation of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,941,525 | July 1, 2023 | April 30, 2028 | POGREBA-BROWN, KRISTEN M | reporter.nih.gov |
| Mechanisms underlying delayed neurocognitive dysfunction in long-covid | NIH | National Institute on Aging | 2023 to 2025 | $1,907,050 | September 1, 2023 | May 31, 2028 | SCHULZ, PAUL E | reporter.nih.gov |
| Assessing the long-term impacts of the COVID-19 pandemic on disparities in cancer screening and follow-up | NIH | National Cancer Institute | 2021 to 2024 | $1,886,468 | July 15, 2021 | July 2, 2024 | DICKERSON, JOHN F | reporter.nih.gov |
| A randomized controlled trial of smell training and trigeminal nerve stimulation in the treatment of COVID-related persistent smell loss | NIH | National Institute on Deafness and Other Communication Disorders | 2023 to 2025 | $1,869,850 | June 1, 2023 | May 31, 2028 | CORTESE, BERNADETTE | reporter.nih.gov |
| Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program to Improve the Functioning of Persons Suffering from Post-acute Sequelae of SARS-CoV-2 infection (PASC): A Randomized Controlled | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,840,273 | April 12, 2023 | March 31, 2027 | DILLINGHAM, TIMOTHY R | reporter.nih.gov |
| Long COVID as a putative subtype of chronic fatigue syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,837,410 | August 18, 2022 | July 31, 2027 | SAXENA, RICHA | reporter.nih.gov |
| Cohort and biomarkers for COVID-19 severity, natural history, and reinfection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $1,790,574 | September 17, 2021 | August 31, 2025 | BLASER, MARTIN J | reporter.nih.gov |
| COVID-19, Inflammation and HPA axis activity, and Risk for Psychopathology in Youth | NIH | National Institute of Mental Health | 2023 to 2024 | $1,583,414 | July 1, 2023 | May 31, 2028 | MELHEM, NADINE M. | reporter.nih.gov |
| Beta cell dysfunction as an acute and a post acute sequelae of COVID19 | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $1,573,424 | August 1, 2022 | July 31, 2025 | GEORGIA, SENTA K | reporter.nih.gov |
| Short-term and long-term impact of COVID-19 on multiple sensory systems | NIH | National Institute on Deafness and Other Communication Disorders | 2023 to 2025 | $1,559,875 | February 1, 2023 | January 31, 2028 | ZHAO, KAI | reporter.nih.gov |
| Long-Term Effects of COVID-19-induced Health Care Delivery Changes on Patient & Workforce Processes & Outcomes in Safety Net Practices Caring for Health Disparity Populations | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2024 | $1,542,586 | August 21, 2022 | April 30, 2025 | STANGE, KURT C | reporter.nih.gov |
| Impact of SARS CoV2 on post-hospital recovery of carbohydrate and muscle metabolism: role of endothelial injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,541,134 | September 15, 2021 | August 31, 2025 | REUSCH, JANE E | reporter.nih.gov |
| Molecular Targets Modulating Neuro COVID Sequelae Linked to Tauopathy | NIH | National Institute on Aging | 2024 to 2025 | $1,484,989 | September 15, 2024 | May 31, 2029 | MOHAPATRA, SUBHRA | reporter.nih.gov |
| Analysis of immunologic mechanisms in patients with chronic lung disease after acute COVID infection | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,479,938 | August 15, 2024 | May 31, 2028 | TWIGG, HOMER L | reporter.nih.gov |
| Mechanisms of Cognitive Control Impairment in ME/CFS and PASC-ME/CFS | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,430,688 | September 1, 2023 | July 31, 2028 | ERYILMAZ, H HAMDI | reporter.nih.gov |
| Mechanisms of anosmia and brain infection in a genetic mouse model of COVID-19 | NIH | National Institute on Deafness and Other Communication Disorders | 2024 to 2025 | $1,423,474 | December 5, 2023 | November 30, 2028 | MILLAR, SARAH E. | reporter.nih.gov |
| Predicting Post-Covid Pulmonary Fibrosis with Explainable Deep Learning and Optimal Biomarker Discovery | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,389,868 | September 1, 2024 | May 31, 2028 | BAGCI, ULAS | reporter.nih.gov |
| Molecular pathogenesis of COVID-19-associated coagulopathy and new therapeutic approaches | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,359,177 | January 1, 2024 | December 31, 2028 | AIOLFI, ROBERTO | reporter.nih.gov |
| Towards a molecular biology of human olfaction in health and disease | NIH | National Institute on Deafness and Other Communication Disorders | 2024 to 2025 | $1,354,376 | September 1, 2024 | July 31, 2029 | GOLDSTEIN, BRADLEY J | reporter.nih.gov |
| Evaluating SARS-CoV-2 spike antigen-induced coagulopathy and neuroinflammation as mechanistic drivers of neurologic PASC | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,312,585 | April 1, 2024 | March 31, 2029 | PELUSO, MICHAEL JOSEPH | reporter.nih.gov |
| Cerebral Energy Metabolism in ME/CFS with and without PASC | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,308,958 | July 1, 2024 | June 30, 2029 | XU, XIANG | reporter.nih.gov |
| Heat Therapy for the treatment of post-acute COVID-19 syndrome | NIH | National Institute on Aging | 2024 to 2025 | $1,294,614 | September 3, 2024 | August 31, 2030 | LAYEC, GWENAEL | reporter.nih.gov |
| Olfactory and neurological manifestations of acute and post-acute murine COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,292,396 | September 23, 2016 | October 31, 2028 | PERLMAN, STANLEY | reporter.nih.gov |
| Immune dysregulation mechanisms of persistent post-COVID19 olfactory dysfunction | NIH | National Institute on Deafness and Other Communication Disorders | 2024 to 2025 | $1,287,704 | July 1, 2024 | June 30, 2029 | BANKOVA, LORA | reporter.nih.gov |
| Statistical Methods in COVID-19/PASC Clinical Research | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,274,077 | March 6, 2023 | February 28, 2027 | FOULKES, ANDREA S | reporter.nih.gov |
| Mechanisms for post-COVID pituitary damage | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,205,900 | September 1, 2021 | July 31, 2025 | ARAKI, TAKAKO | reporter.nih.gov |
| Post COVID-19 Neuro-Cognitive Manifestations and Underlying Mechanisms in Older African Americans | NIH | National Institute on Aging | 2025 | $1,177,717 | August 20, 2022 | July 31, 2027 | HAJJAR, IHAB M | reporter.nih.gov |
| Assessing the long-term impacts of the COVID-19 pandemic on disparities in cancer screening and follow-up (RESTORE) | NIH | National Cancer Institute | 2024 to 2025 | $1,174,468 | July 15, 2021 | June 30, 2027 | CORONADO, GLORIA D. | reporter.nih.gov |
| Sex differences in hypertension, cognitive function and renal hemodynamics; a role for B cells and autoantibodies | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,002,100 | June 1, 2024 | May 31, 2028 | LAMARCA, BABBETTE | reporter.nih.gov |
| Covid-19 induced worsening of glomerular diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $994,136 | March 15, 2023 | December 31, 2027 | MACE, CAMILLE EMILIE ADELINE | reporter.nih.gov |
| Epidemiologic and Translational Investigation of Long-Term Kidney Outcomes After COVID-19 | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $990,324 | April 1, 2021 | December 31, 2026 | MENEZ, STEVEN | reporter.nih.gov |
| Mentoring in Patient-Oriented HIV Research in the Era of Universal ART | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $928,483 | March 1, 2017 | June 30, 2027 | LOCKMAN, SHAHIN | reporter.nih.gov |
| Assessing the mechanisms underlying female sex-predominance in Long COVID | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $913,012 | August 22, 2025 | July 31, 2030 | PELUSO, MICHAEL JOSEPH | reporter.nih.gov |
| Neurocognitive & neuropsychiatric impact of chemosensory alterations: Implications of olfactory dysfunction in COVID-19 | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $893,050 | June 1, 2021 | May 31, 2027 | OVERDEVEST, JONATHAN B | reporter.nih.gov |
| SARS-CoV-2 and Social Determinants of Health Impact on Inflammation Associated Depression Risk (SSIDR) | NIH | National Institute of Mental Health | 2024 | $833,123 | July 5, 2024 | April 30, 2029 | KIM, LINDA Y. | reporter.nih.gov |
| Multi Parametric Total-Body Imaging of Immune Activation in Post Acute Sequelae of SARS-CoV-2 (PASC) | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $808,672 | August 1, 2025 | July 31, 2029 | OMIDVARI, NEGAR | reporter.nih.gov |
| Assessing the Long-term Impact of COVID-induced Telemedicine Expansion on Dementia Care | NIH | National Institute on Aging | 2025 | $806,018 | June 1, 2022 | May 31, 2027 | ADLER-MILSTEIN, JULIA ROSE | reporter.nih.gov |
| Targeting cerebrovascular Wnt/beta-catenin signaling to reverse brain endothelial damage induced by SARS-CoV-2 infection | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $801,329 | December 1, 2024 | November 30, 2029 | LUTZ, SARAH ELIZABETH | reporter.nih.gov |
| Understanding Circuit Dysfunction in Post-Acute Sequelae of SARS-CoV-2 Infection | NIH | National Institute of Mental Health | 2025 | $797,157 | December 1, 2024 | October 31, 2029 | CONSTABLE, R TODD | reporter.nih.gov |
| Collision of Alzheimers disease and COVID-19 pandemic in the United States: risks, outcomes, disparities and treatments | NIH | National Institute on Aging | 2025 | $772,838 | May 1, 2022 | April 30, 2027 | XU, RONG | reporter.nih.gov |
| Pathogenic mechanisms of chronic lung sequelae following respiratory viral infection | NIH | National Heart, Lung, and Blood Institute | 2025 | $754,729 | August 10, 2025 | May 31, 2029 | ZHANG, LIANGHUI | reporter.nih.gov |
| Evaluating the Epidemiology and Determinants of Neurologic Post-acute Sequelae of SARS-CoV-2 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $753,698 | August 16, 2022 | July 31, 2026 | PURPURA, LAWRENCE JAMES | reporter.nih.gov |
| Impact of Alcohol Misuse on Cognitive and Respiratory Outcomes in COVID-19-associated Acute Respiratory Failure | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $727,247 | September 22, 2021 | August 31, 2025 | BURNHAM, ELLEN L | reporter.nih.gov |
| Acute and Long-Term Impact of SARS-CoV-2 Infection and its Interaction with APOE on Cognitive Function and Neuropathology in Aging and Alzheimer's Disease | NIH | National Institute on Aging | 2025 | $699,107 | June 15, 2022 | May 31, 2027 | LI, LING | reporter.nih.gov |
| Pain Relief with Integrative Medicine (PRIMEe)?: Feasibility Trial of Acupuncture for Long COVID | NIH | National Center for Complementary & Integrative Health | 2024 | $656,157 | February 26, 2024 | January 31, 2027 | GENTILE, NIKKI | reporter.nih.gov |
| Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2 | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $654,367 | January 1, 2025 | December 31, 2029 | CHIB, VIKRAM S | reporter.nih.gov |
| Investigating Mechanisms of Neurological Post Acute Sequelae of SARS CoV2 Using Quantitative Multiparametric In-Vivo and Ex-Vivo MRI | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $634,622 | December 1, 2024 | November 30, 2029 | SEIFERT, ALAN C | reporter.nih.gov |
| Pathogenic Mechanism and Therapeutic Approaches for Exercise Intolerance in Post-Acute Sequelae of COVID-19 | NIH | National Heart, Lung, and Blood Institute | 2025 | $633,045 | April 1, 2025 | January 31, 2029 | ZHANG, LIANGHUI | reporter.nih.gov |
| Microbiota-Mediated Bidirectional Interactions Between Alcohol Misuse and Post-COVID-19 Syndrome | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $631,668 | September 22, 2021 | August 31, 2025 | KESHAVARZIAN, ALI | reporter.nih.gov |
| Novel animal models to dissect how lung macrophages contribute to SARS-CoV2 alveolar pathology and respiratory failure | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $615,667 | December 1, 2021 | November 30, 2026 | GLUDISH, DAVID W | reporter.nih.gov |
| Rapid Sample Preparation and Ultrasensitive Detection of COVID-19 in Human Saliva | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2023 | $607,030 | August 1, 2021 | April 30, 2025 | WONG, TAK SING | reporter.nih.gov |
| Affinity Reagents for the Immune System of Golden Hamster (for SARS-CoV-2 induced long-COVID disease) | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $600,000 | September 1, 2023 | August 31, 2025 | QI, HONG | reporter.nih.gov |
| Mechanisms of Immune Dysfunction in Oral Post-Acute Sequelae of Covid-19 | NIH | National Institute of Dental & Craniofacial Research | 2023 | $581,037 | September 13, 2023 | September 12, 2025 | NAQVI, AFSAR RAZA | reporter.nih.gov |
| SARS-CoV-2 and Social Determinants of Health Impact on Inflammation Associated Depression Risk (SSIDR) | NIH | National Institute of Mental Health | 2025 | $565,604 | July 5, 2024 | August 31, 2029 | KIM, LINDA Y. | reporter.nih.gov |
| Impact of SARS-CoV-2 on the cerebrovasculature as a risk factor for VCID: Role of Wnt/beta-catenin | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $561,155 | July 15, 2024 | June 30, 2025 | LUTZ, SARAH ELIZABETH | reporter.nih.gov |
| Mechanistic Investigation of Neuropathological Interactions between COVID-19 and Progression of Lewy Pathology and Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $506,052 | August 1, 2024 | July 31, 2025 | LU, XIAOHONG | reporter.nih.gov |
| Mechanisms of Thrombosis in SARS CoV-2 Infection | NIH | National Heart, Lung, and Blood Institute | 2025 | $503,637 | January 15, 2025 | November 30, 2028 | WOOD, JEREMY P | reporter.nih.gov |
| Structural and Metabolic Neuroimaging of ME/CFS Occurring with and without COVID-19 Infection | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $464,750 | March 1, 2022 | February 28, 2025 | XU, XIANG | reporter.nih.gov |
| Identification of Risk Factors for predicting outcomes of COVID-19-Related Multisystem Inflammatory Syndrome in Children (MISC) using Real World Clinical Data | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $463,464 | August 8, 2022 | July 31, 2025 | WALUNAS, THERESA L | reporter.nih.gov |
| Magnetic Resonance Imaging Biomarkers of Post-COVID-19 Cerebral Microvascular Dysfunction | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $463,049 | May 15, 2024 | March 31, 2029 | MCALPINE, LINDSAY SARAH | reporter.nih.gov |
| Correlating neutrophil function and plasma cytokine profiles with progression of ME/CFS and Long-Covid/PASC | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $462,000 | December 5, 2022 | November 30, 2025 | ELLETT, FELIX | reporter.nih.gov |
| Preventing Infections and Antimicrobial Resistance in the Aging Population: Translational Research and Training Program | NIH | National Institute on Aging | 2022 to 2025 | $459,644 | August 1, 2015 | January 31, 2027 | MODY, LONA | reporter.nih.gov |
| Glial activation and metabolite contributions to 'brain fog' post-acute sequelae of COVID-19 (PASC) | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $459,250 | August 1, 2023 | July 31, 2025 | VANELZAKKER, MICHAEL B | reporter.nih.gov |
| Bioengineering a human microphysiological system for elucidation of viral peripheral neurotropism of RSV and SARS-CoV-2 | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $457,778 | September 5, 2025 | August 31, 2027 | MOORE, MICHAEL J | reporter.nih.gov |
| Notch regulation of airway epithelial-immune cell cross-talk in SARS-CoV-2 infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $448,688 | July 9, 2025 | June 30, 2027 | DESHMUKH, UMESH S | reporter.nih.gov |
| Roles of human surfactant collectin variants in the susceptibility of COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $448,250 | July 8, 2022 | June 30, 2025 | WANG, GUIRONG | reporter.nih.gov |
| Characterizing subphenotypes of long COIVD in patients with sickle cell disease | NIH | National Institute on Minority Health and Health Disparities | 2024 to 2025 | $445,920 | May 30, 2024 | December 31, 2026 | SHARATHKUMAR, ANJALI ALATKAR | reporter.nih.gov |
| Mechanism of the short- and long-term effects of COVID-19-induced Alarmins on hematopoietic stem and progenitor cells. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $435,732 | July 1, 2023 | June 30, 2025 | LIANG, YING | reporter.nih.gov |
| Therapy for long-COVID in a preclinical model | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $433,125 | July 11, 2024 | May 31, 2027 | KAUFMAN, DANIEL | reporter.nih.gov |
| Impact of SARS-Cov-2 on a Rat Model Cerebral Amyloid Angiopathy | NIH | National Institute on Aging | 2024 to 2025 | $433,125 | September 15, 2024 | May 31, 2027 | VAN NOSTRAND, WILLIAM E. | reporter.nih.gov |
| Auditory Insights into Post-Acute Sequelae of SARS-CoV-2 Infection: Unveiling Abnormal Auditory Perception and Diagnostic Markers through Complex Auditory Performance Tests. | NIH | National Institute on Deafness and Other Communication Disorders | 2025 | $432,632 | September 1, 2025 | August 31, 2027 | NIEMCZAK, CHRISTOPHER EDWARD | reporter.nih.gov |
| The Unilateral Mosaic (UMos): Novel tools to compartmentalize pathology and trace cellular interactions in mouse models of human disease | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $431,750 | September 1, 2024 | June 30, 2026 | GLUDISH, DAVID W | reporter.nih.gov |
| Cognitive strategy training in Post-COVID-19 Syndrome: A feasibility trial. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $430,375 | September 19, 2023 | August 31, 2025 | BOONE, ANNA | reporter.nih.gov |
| Leveraging iPSC technology to understand neuro-immune responses to SARS-CoV-2 variants | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $430,375 | April 15, 2024 | March 31, 2026 | WEN, ZHEXING | reporter.nih.gov |
| Neurovascular Uncoupling and Cognitive Impairments of Long COVID in Aging | NIH | National Institute on Aging | 2022 to 2023 | $429,000 | September 30, 2022 | August 31, 2024 | WANG, YANG | reporter.nih.gov |
| COVID-19 related inflammation as a risk factor for age-related cognitive decline and Alzheimer's Disease | NIH | National Institute on Aging | 2023 to 2024 | $429,000 | April 1, 2023 | March 31, 2025 | TRONSON, NATALIE CELIA | reporter.nih.gov |
| Chitin and chitinases in SARS-CoV-2 infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $427,834 | June 1, 2023 | May 31, 2025 | VAN DYKEN, STEVEN | reporter.nih.gov |
| A Novel Cell-based System for the Search of SARS-CoV-2 ORF3a Inhibitors against COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $427,625 | June 21, 2024 | April 30, 2027 | ZHAO, RICHARD YUQI | reporter.nih.gov |
| Autoimmune responses associated with SARS-CoV-2 infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $421,639 | April 19, 2022 | March 31, 2025 | WHEELER, SARAH E. | reporter.nih.gov |
| Can SARS-CoV-2 proteins accelerate Abeta pathology in fly and mouse models of AD? | NIH | National Institute on Aging | 2025 | $419,375 | January 1, 2025 | December 31, 2026 | RINCON-LIMAS, DIEGO E | reporter.nih.gov |
| Liposome fusion enabled extracellular vesicle detection for COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $419,146 | June 1, 2022 | May 31, 2025 | NING, BO | reporter.nih.gov |
| Targeting SARS-CoV-2 induced lung immunopathology using novel genetic mouse models | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $419,072 | May 9, 2022 | April 30, 2025 | TUMANOV, ALEXEI V | reporter.nih.gov |
| Pathogenesis of myalgia and fatigue after SARS-CoV-2 infection | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $416,626 | September 23, 2022 | August 31, 2024 | HOMMA, SACHIKO | reporter.nih.gov |
| Interaction of Biopsychosocial Stress, Alcohol Misuse, and Neurobehavioral Sequelae of COVID-19 | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2023 | $404,250 | September 1, 2022 | August 31, 2025 | FERGUSON, TEKEDA F. | reporter.nih.gov |
| Informatics Approach to Identification and Deep Phenotyping of PASC Cases | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $398,311 | September 6, 2022 | August 31, 2025 | LI, XIAOMING | reporter.nih.gov |
| Investigating fibrinogen as a pathologic and targetable mediator of COVID-19-associated coagulopathy | NIH | National Heart, Lung, and Blood Institute | 2025 | $391,250 | March 1, 2025 | February 29, 2028 | MAIER, CHERYL | reporter.nih.gov |
| The neuroimmune mechanism of SARS-CoV-2 on synaptic transmission and plasticity | NIH | National Institute of Mental Health | 2025 | $384,772 | January 10, 2025 | November 30, 2028 | DU, JIANYANG | reporter.nih.gov |
| Development of an accessible Cognitive Behavioral Therapy digital therapeutic for individuals with Long COVID | NIH | National Institute of Nursing Research | 2025 | $383,159 | September 16, 2025 | August 30, 2026 | RANDA, LAURA | reporter.nih.gov |
| A Diet Intervention Study To Mitigate Fatigue Symptoms And To Improve Muscle And Physical Function In Older Adults With Post-Acute COVID-19 Syndrome | NIH | National Institute on Aging | 2023 to 2025 | $372,681 | August 15, 2023 | July 31, 2028 | BIGMAN, GALYA | reporter.nih.gov |
| Mathematical Modeling and Scientific Computing for Infectious Disease Research | NIH | National Institute of General Medical Sciences | 2023 | $331,246 | September 22, 2023 | March 10, 2025 | WANG, JIN | reporter.nih.gov |
| Characterizing neurocognitive deficits in post-acute sequelae of COVID-19 | NIH | National Institute on Aging | 2025 | $325,672 | September 16, 2025 | May 31, 2027 | MEGHDADI, AMIR HOSSEIN | reporter.nih.gov |
| Long COVID Health Literacy Project: Bringing Health Information to Patients and Providers with Health Disparities in Rural Northern New England | NIH | National Library of Medicine | 2024 to 2025 | $300,000 | September 1, 2024 | July 10, 2027 | PARSONNET, JEFFREY | reporter.nih.gov |
| Examining the Interplay of COVID-19 and HIV: Impacts on HIV Care, and Long-Term Outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $297,648 | August 2, 2024 | July 31, 2029 | ROBERTSON, MCKAYLEE | reporter.nih.gov |
| Development of Antisense Oligonucleotides to Regulate Gamma' Fibrinogen Levels | NIH | National Heart, Lung, and Blood Institute | 2023 | $277,710 | August 24, 2023 | July 31, 2025 | FARRELL, DAVID HENRY | reporter.nih.gov |
| The Development of CSD peptides for the therapeutic treatment of post-acute sequelae of COVID-19 (PACS) | NIH | National Heart, Lung, and Blood Institute | 2023 | $259,332 | September 15, 2023 | July 31, 2024 | MACKENZIE, BREANNE | reporter.nih.gov |
| Comparative, single-cell analysis of COVID-19 and other respiratory diseases | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $253,500 | March 1, 2022 | February 29, 2024 | TSANKOV, ALEXANDER MINCHEV | reporter.nih.gov |
| Neurobiological Mechanisms of Fatigue in Health and after COVID-19 | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $249,000 | July 1, 2023 | August 31, 2028 | CASAMENTO MORAN, AGOSTINA | reporter.nih.gov |
| Utilizing a novel hamster model to determine neurologic and behavioral abnormalities of offspring from mothers infected with SARS-CoV-2 | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $240,000 | December 15, 2024 | November 30, 2026 | PLANTE, KENNETH STEVEN | reporter.nih.gov |
| Impact of SARS CoV2 on Human Herpesvirus Co-Infections | NIH | National Heart, Lung, and Blood Institute | 2025 | $234,000 | September 1, 2025 | August 31, 2027 | SKALSKY, REBECCA L | reporter.nih.gov |
| Post-Infectious Dysautonomia: Insights into Clinical Phenotypes and Disease Pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $198,720 | January 1, 2025 | December 31, 2029 | ADLER, BRITTANY LEE | reporter.nih.gov |
| Neurobiological Mechanisms of Fatigue in Health and after COVID-19 | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $198,226 | July 1, 2023 | June 30, 2025 | CASAMENTO MORAN, AGOSTINA | reporter.nih.gov |
| Modeling the dynamics and composition of T-cell receptor repertoires in post-acute sequelae of COVID-19 (PASC) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $194,942 | December 18, 2023 | October 31, 2025 | HADLOCK, JENNIFER | reporter.nih.gov |
| Integrated Cognitive Rehabilitation and Cognitive Behavioral Therapy Intervention for patients with Post-COVID-19 Cognitive Impairment and Depression | NIH | National Institute of Mental Health | 2025 | $194,157 | December 1, 2024 | November 30, 2029 | BECKER, JACQUELINE HELCER | reporter.nih.gov |
| Applying a Targeted Machine Learning and Causal Inference Approach to Analyzing Long-Term Sequelae of COVID-19 Infection Through the National COVID Cohort Collaborative. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $190,688 | September 4, 2024 | May 31, 2026 | BUTZIN-DOZIER, ZACHARY | reporter.nih.gov |
| Leveraging the sensitivity of antigen-specific T cells to interrogate disease mechanisms and identify therapeutic targets for Long COVID | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $175,428 | August 1, 2025 | July 31, 2027 | PAINTER, MARK M | reporter.nih.gov |
| Computerized Cognitive Remediation of Postviral Neurocognitive Dysfunction in Older Adults | NIH | National Institute on Aging | 2025 | $168,775 | August 1, 2025 | April 30, 2030 | LINDBERGH, CUTTER AUGUSTUS | reporter.nih.gov |
| Elucidating the lineage dynamics of optimal human CD8 T cell responses to SARS-CoV-2 and how CD8 T cell homeostasis is altered in Long COVID | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $159,980 | May 1, 2024 | April 30, 2027 | PAINTER, MARK M | reporter.nih.gov |
| Analysis of clinical trial data to better understand Long Covid | NIH | National Center for Advancing Translational Sciences | 2025 | $155,000 | September 5, 2025 | August 31, 2027 | BRAMANTE, CAROLYN T | reporter.nih.gov |
| The Use of Human Cardiac Organoids to Model COVID-19 Cytokine Storm Induced Cardiac Injury | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $150,527 | May 1, 2022 | April 30, 2025 | ARHONTOULIS, DIMITRIOS CHRISOVALANTOU | reporter.nih.gov |
| Cytokine-mediated neurologic disease in COVID-19 | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $142,074 | September 1, 2022 | August 31, 2024 | VANDERHEIDEN, ABIGAIL ROSE | reporter.nih.gov |
| Impacts of SARS-CoV-2 Infection and Age on Musculoskeletal Health | NIH | National Institute on Aging | 2022 to 2024 | $120,928 | September 1, 2022 | August 31, 2025 | AWOSANYA, OLATUNDUN DUPE | reporter.nih.gov |
| Investigating the role of T cells in promoting post-acute memory deficits after COVID-19 in mice | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $107,995 | July 7, 2025 | June 30, 2027 | VANDERHEIDEN, ABIGAIL ROSE | reporter.nih.gov |
| The Impact of SARS-CoV-2 Infection and Vaccination on the Risk of Alzheimer’s Disease and Related Dementias | NIH | National Institute on Aging | 2025 | $86,020 | December 1, 2023 | May 31, 2029 | WANG, JINGXUAN | reporter.nih.gov |
| Exploring the role of hyper-phagocytic microglia and SYK signaling in the aged hippocampus during COVID-19 | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $75,650 | March 1, 2024 | November 30, 2026 | NATALE, NICK | reporter.nih.gov |
| Structural, Functional, and Neurobehavioral Consequences of Adolescent COVID-19 | NIH | National Institute of Mental Health | 2024 to 2025 | $73,750 | April 1, 2024 | March 31, 2027 | RYAN, MEGHANN | reporter.nih.gov |
| The Impact of SARS-CoV-2 Infection and Vaccination on the Risk of Alzheimer’s Disease and Related Dementias | NIH | National Institute on Aging | 2023 to 2025 | $71,667 | December 1, 2023 | June 15, 2025 | WANG, JINGXUAN | reporter.nih.gov |
| 25th International Workshop on Long-term Complications of HIV and SARS-CoV-2 | NIH | National Heart, Lung, and Blood Institute | 2023 | $68,333 | September 16, 2023 | August 31, 2024 | BROWN, TODD T | reporter.nih.gov |
| Early life influenza infection and glial dysregulation | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $49,538 | September 1, 2025 | August 31, 2028 | MALACON, KAREN ELIZABETH | reporter.nih.gov |
| 2023 Lung Development, Injury and Repair Gordon Research Conference and Gordon Research Seminar | NIH | National Heart, Lung, and Blood Institute | 2023 | $45,000 | May 1, 2023 | April 30, 2024 | SUN, XIN | reporter.nih.gov |
| HIV and its impact on Long COVID prevalence and manifestations | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $43,420 | August 22, 2025 | August 21, 2028 | OPSTEEN, SKYE | reporter.nih.gov |
| Investigating the Role of Epstein-Barr Virus in Long COVID Pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $33,538 | January 16, 2026 | January 15, 2028 | TABACHNIKOVA, ALEXANDRA | reporter.nih.gov |
| An epidemiological study to investigate the multifactoral nature of diabetes risk among adults with COVID-19 with a genetic and social determinants of health lens | NIH | National Institute of Nursing Research | 2024 | $32,974 | January 1, 2025 | December 31, 2026 | KEELS, JORDAN | reporter.nih.gov |
| Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment | NIH | National Heart, Lung, and Blood Institute | 2023 | $21,300 | August 15, 2023 | July 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Viral Infection and Inflammation Workshop 2024 | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $7,000 | July 17, 2024 | June 30, 2025 | KURITZKES, DANIEL R. | reporter.nih.gov |
| The 2024 conference on "Epithelial mesenchymal interactions in lung development and fibrosis" | NIH | National Heart, Lung, and Blood Institute | 2024 | $5,000 | October 1, 2024 | September 30, 2025 | DE LANGHE, STIJN PIET JOHAN | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 129 | $86,970,754 | 0 | $0 |
| 2024 | 114 | $231,899,774 | 0 | $0 |
| 2023 | 111 | $182,674,403 | 0 | $0 |
| 2022 | 63 | $73,269,551 | 0 | $0 |
| 2021 | 19 | $572,914,986 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 2 awards here | |
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) | PA-24-194 | NIH | May 7, 2027 | Not listed | Notice number printed on 2 awards here | |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required) | PA-24-184 | NIH | May 8, 2027 | Not listed | Notice number printed on 1 award here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 39 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 39 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 39 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 39 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 39 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 39 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 39 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 39 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 39 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 39 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 39 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 39 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 39 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 39 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 39 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 39 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 39 awards here |
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.